SOURCE: Oasis Consumer Healthcare
CLEVELAND, OH--(Marketwire - Aug 7, 2012) - Science has proven that germs can stay infectious and airborne for hours. If someone sneezes or coughs in the morning, their germs can linger in the air and infect another person hours later. In fact, 75 percent of daycares, 33 percent of medical offices and 67 percent of airplanes have enough airborne viruses to infect someone in one hour.1
Just in time for back to school and cough and cold season, Oasis Consumer Healthcare is making it safer to breathe the air you share with new Halo Oral Antiseptic. Halo is the first-ever, patent-pending, oral antiseptic spray that has been scientifically proven to kill 99.9 percent of infectious airborne germs, including a broad spectrum of bacteria and viruses, such as rhinovirus (the virus that causes the common cold), influenza and H1N1, and is clinically proven to kill airborne germs you breathe in for up to six hours.
The active ingredient, Cetylpyridinium chloride (CPC, 0.1%), is an FDA-monographed oral antiseptic with a remarkably strong history of safety and efficacy. Once Halo is sprayed into the mouth, it coats the back of the oral cavity, or oropharynx, to provide a sustained antiseptic action that blocks and kills airborne germs breathed in through the nose and mouth. The mouth is the single largest entry point for germs, and in six hours, the average person breathes nearly 600 gallons of air2 that may contain infectious germs from other people's coughs, sneezes and breath vapor.
"Exposure to airborne germs is inevitable -- especially in crowded environments and when traveling," said Dr. Mahmoud Ghannoum, Director for the Center for Medical Mycology and the Mycology Reference Laboratory at University Hospitals Case Medical Center and Case Western Reserve University. "Unlike other products that support the immune system or protect from germs on surfaces or hands, Halo is the first and only product of its kind to offer protection from airborne germs."
The results from independent scientific studies and clinical trials on Halo's efficacy -- which were conducted at University Hospitals Case Medical Center -- have been accepted for presentation at and publication by the Infectious Disease Society of America (IDSA) and the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), two of the leading medical societies in the United States.
Halo is available in the cough and cold section at major retailers nationwide in a convenient, travel-size 1 fl oz. (30 ml) bottle, providing 35 doses for a suggested retail price of $12.99. There are two flavors for adults, berry and citrus, and a grape flavor for children ages two and up. Halo is alcohol-, dye- and sugar-free.
For more information about Halo and the dangers of airborne germs, visit www.halogermdefense.com and Halo Oral Antiseptic on Facebook and Twitter.
Twitter Cue: @HaloGermDefense offers Protection From the #AirYouShare
Halo and Protection From the Air You Share are trademarks of Oasis Consumer Healthcare.
1 Concentrations and size distributions of airborne influenza A viruses measured indoors at a health center, a daycare center and on an airplane. Wan Yang, Subbiah Elankumaran and Linsey C. Marr J.R. Soc. Interface published online 7 February 2011 doi: 10.1098/rsif.2010.0686
2 Learn About Germs. http://learnaboutgerms.arizona.edu/how_germs_spread.htm. Accessed July 20, 2012.
About Oasis Consumer Healthcare
Oasis Consumer Healthcare, the maker of leading over-the-counter healthcare products for all ages, is owned by doctors, dentists, and scientists in America's medical capital, Cleveland, Ohio, home to such noted organizations as the Cleveland Clinic, University Hospitals and Case Western Reserve University. With science and innovation as our foundation, Oasis continues to put the latest science to work by creating leading edge products for the health and beauty market.